SEC Form 4 · accession 0001104659-17-038465
AGILE THERAPEUTICS INC · AGRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
William McKee
Director
Period of report
Jun 8, 2017
Accepted (ET)
Jun 9, 2017 · 5:04 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001261249
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F1 | $3.90 | Jun 8, 2017 | A | 14,000 | A | — | Jun 7, 2027 | Common Stock | 14,000 | 14,000 | D |
| Restricted Stock UnitsF2,F3 | — | Jun 8, 2017 | A | 17,949 | A | — | — | Common Stock | 17,949 | 17,949 | D |
Explanation of responses
- F1The option was granted on June 8, 2017 and vests in full on June 8, 2018, subject to the Reporting Person's continued service on the Issuer's board of directors through the vesting date and provided that the Reporting Person attends at least 75% of the board meetings held during the year of board service.
- F2Each restricted stock unit represents a contingent right to receive one share of common stock.
- F3The restricted stock units were granted on June 8, 2017 and vest in full on June 8, 2018, subject to the Reporting Person's continued service on the Issuer's board of directors through the vesting date and provided that the Reporting Person attends at least 75% of the board meetings held during the year of board service.